AUTL - Autolus Therapeutics plc


1.48
0.060   4.054%

Share volume: 1,538,589
Last Updated: 04-28-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances: 0.20%

PREVIOUS CLOSE
CHG
CHG%

$1.42
0.06
0.04%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 03-31-2024 06-30-2024 09-30-2024 12-31-2024 03-31-2025 06-30-2025 09-30-2025 12-31-2025
Fiscal Quarter Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025
Report Date 05-17-2024 08-08-2024 11-12-2024 03-20-2025 05-08-2025 08-12-2025 11-12-2025 03-27-2026
Total revenue 10.091 M 0.000 0.000 29.000 K 8.982 M 20.923 M 21.194 M 24.289 M
Cost of revenue 0.000 0.000 0.000 11.387 M 17.951 M 24.445 M 28.643 M 25.330 M
Gross profit 10.091 M 0.000 0.000 -11.358 M -8.969 M -3.522 M -7.449 M -1.041 M
    -100.00% nan% inf% 21.03% 60.73% -111.50% 86.02%  
Operating expenses 48.848 M 58.515 M 67.653 M 64.506 M 56.268 M 57.695 M 64.172 M 71.428 M
Selling general and admin 18.177 M 21.903 M 27.330 M 33.676 M 29.534 M 30.265 M 36.280 M 35.795 M
Research and development 30.671 M 36.612 M 40.323 M 30.830 M 26.734 M 27.430 M 27.892 M 35.633 M
Total expenses 48.848 M 58.515 M 67.876 M 64.920 M 56.271 M 57.695 M 64.172 M 71.425 M
    19.79% 16.00% -4.36% -13.32% 2.53% 11.23% 11.30%  
Operating income -38.757 M -58.929 M -67.876 M -75.864 M -65.240 M -61.217 M -71.621 M -72.466 M
Ebit -40.362 M -57.409 M -79.706 M -64.718 M -63.930 M -59.583 M -72.448 M -71.905 M
Pretax income -52.698 M -58.221 M -82.072 M -26.143 M -67.936 M -47.520 M -78.586 M -91.514 M
    10.48% 40.97% -68.15% 159.86% -30.05% 65.37% 16.45%  
Income tax -8.000 K 51.000 K 22.000 K 1.463 M 2.225 M 397.000 K 532.000 K -1.182 M
Net income basic 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
                   
Net income -52.690 M -58.272 M -82.094 M -27.606 M -70.161 M -47.917 M -79.118 M -90.332 M
    -10.59% -40.88% 66.37% -154.15% 31.70% -65.11% -14.17%